The 20 Best Chondrosarcoma Doctors Near Me in Ann Arbor, MI

Rama Rao is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Rao is board certified in Pediatric Hematology-Oncology.

Dr. Biermann serves as Director of the Musculoskeletal Oncology Program at the University of Michigan. Her clinical interests include malignant and benign tumors of soft tissue and bone, both primary and metastatic. Her practice includes both adults and children. Dr. Biermann chairs the Multidisciplinary Sarcoma Tumor Board, a collaborative cancer center group including medical and pediatric oncologists, pathologist, diagnostic radiologists, and radiation therapists. The Sarcoma clinic meets weekly. The University of Michigan Sarcoma team engages in patient care, clinical trials, and basic science research. In addition to her regional responsibilities, Dr. Biermann has been active in national committee and administrative work. She chairs the National Comprehensive Cancer Network (NCCN) Bone Tumors Panel. She is past president of the Musculoskeletal Tumor Society (MSTS). She is a member of the American Society of Clinical Oncology (ASCO). She sits on the Orthopaedic Research and Education Foundation (OREF) Grant Board. Her active research program has included more than 87 publications in the areas of musculoskeletal tumors and in the impact of the Internet on patient education. Dr. Biermann is the University of Michigan Medical Director for the Sarcoma Program and the Orthopaedic Surgery Residency Program Director. Dr. Biermann is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Ewing Sarcoma, Bone Tumor, Chondrosarcoma, Osteosarcoma, and Hip Replacement. Dr. Biermann is board certified in Orthopedic Surgery.

Scott Schuetze is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.

Dr. Geoffrey Siegel is a Michigan native who received his Medical Doctorate Degree at the Detroit Medical Center and his residency in Orthopaedic Surgery at Wayne State University. After finishing his fellowship in Orthopaedic Oncology at Vanderbilt University Medical Center in Nashville, Tennessee, he joined the Department of Orthopaedic Surgery at the University of Michigan as Clinical Assistant Professor.Dr. Siegel's clinical interests are in the treatment of benign and malignant disease, both metastatic as well as primary bone cancer in adults and children. His surgical interests include limb salvage and complex musculoskeletal reconstruction. He enjoys both resident and community physician education in the field of Musculoskeletal Oncology. Dr. Siegel is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Chondrosarcoma, Epithelioid Sarcoma, and Hip Replacement. Dr. Siegel is board certified in Orthopedic Sports Medicine and Orthopedic Surgery.

Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Ganglioneuroblastoma, Rhabdomyosarcoma, Rhabdoid Tumor Predisposition Syndrome, and Rhabdoid Tumor.

Dr. Nick Szerlip is originally from New York, just north of Manhattan, but lived many places around the country while growing up. He attended Columbia University for his undergraduate studies, where he obtained a bachelor’s degree in psychology. He then attended Tulane University School of Medicine in New Orleans, where he obtained his medical degree. After graduating medical school, Dr. Szerlip completed his residency training at the University of Maryland in Baltimore.Dr. Szerlip obtained additional fellowship training during a fellowship at the National Institutes of Health (NIH), where he examined the origins of cancer cells and effective drug delivery to treat cancer, followed by a fellowship in neurosurgical oncology at Memorial Sloan Kettering Cancer Center in New York. The direction of his neurosurgical career has largely been shaped by the loss of his mother to metastatic cancer in the early part of his neurosurgery residency. Her legacy drives him to be a better physician, to search for a solution to spine cancer, and to train future neurosurgeons to approach their patients with the skill, compassion, and respect they deserve during a very difficult time.Clinically, Dr. Szerlip treats disorders of the spine including arthritis, malalignment and specializes in surgical and radiation treatment of spine tumors. His goal at the University of Michigan is to continue to build a clinical and translational spine oncology program that will enable the clinic and the laboratory to work together as partners to rapidly advance care for spine cancer. This model will foster synergy among physicians and researchers, affording our patients access to the latest clinical trials and outstanding, compassionate care; it will also accelerate new therapies for future patients. Dr. Szerlip is rated as an Advanced provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Hemangioblastoma, Fractured Spine, Laminectomy, and Microdiscectomy. Dr. Szerlip is board certified in Neurological Surgery.

Mary Mcgrath is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Mcgrath is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Factor 11 Deficiency, Hemophilia A, Hemophilic Arthropathy, and Glanzmann Thrombasthenia. Dr. Mcgrath is board certified in Pediatric Hematology-Oncology and Pediatrics.

Hugh Garton is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Garton is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 1, Chiari Malformation Type 2, Posterior Fossa Decompression, and Gamma Knife Radiosurgery. Dr. Garton is board certified in Neurological Surgery.

David Svilar is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Svilar is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. His clinical expertise encompasses Sickle Cell Disease, Hereditary Spherocytosis, Febrile Neutropenia, and Shwartzman Phenomenon. Dr. Svilar is board certified in Pediatric Hematology-Oncology and Pediatrics.

Dr. Hearn is an Associate Professor in the Department of Radiation Oncology at the University of Michigan. He completed his medical training at Harvard Medical School and his residency in radiation oncology at Cleveland Clinic. Dr. Hearn investigates mechanisms by which prostate cancer may become resistant to current treatments.Dr. Hearn also treats bladder cancer and has been impressed by the promising responses (sometimes dramatic and long-lasting) that some patients with bladder cancer have when treated with immunotherapy to harness the body’s immune system. He is interested in the intersection of immunotherapy and radiation therapy.Additionally, Dr. Hearn is interested in novel techniques to improve the safety and efficacy of radiation therapy for lung cancer by modulating cytokines relevant to lung injury. Dr. Hearn is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Hearn is board certified in Radiation Oncology.

Dr. Cuneo grew up in Northern California. He studied Biological and Environmental Engineering at Cornell University in Ithaca, NY. Dr. Cuneo received his Doctor of Medicine degree from Vanderbilt University School of Medicine in 2007 and completed an internship there in 2008. In 2008 he started his residency in Radiation Oncology at Duke University Medical Center. Dr. Cuneo has been an Assistant Professor in the Department of Radiation Oncology at the University of Michigan since 2012. Dr. Cuneo is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Liposarcoma, Liver Cancer, and Pancreaticoduodenectomy. Dr. Cuneo is board certified in Radiation Oncology.

Dr. Morikawa joined the faculty in August 2014. After earning her M.Mus. in Piano Performance and M.PH in Epidemiology and Biostatistics from Boston University, Dr. Morikawa received her MD/Ph.D. at the Emory University School of Medicine. After completing her internal medicine residency training at Emory, she underwent fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center. In 2014, she joined the faculty of the University of Michigan. She specializes in the care of patients with breast cancer at the Rogel Cancer Center. Her research involves clinical and translational investigations in breast cancer as well as brain and leptomeningeal metastases from solid tumors. Dr. Morikawa is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Morikawa is board certified in Internal Medicine and Medical Oncology.

Victoria Wytiaz is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Wytiaz is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Desmoid Tumor, Bone Tumor, Synovial Sarcoma, and Rhabdoid Tumor. Dr. Wytiaz is board certified in Pediatrics, Medical Oncology, and Internal Medicine.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Dr. Jeffrey Smerage is a hematologist/oncologist specializing in breast cancer. He received both a medical and doctoral degree from the University of Florida and then went on to residency training at the University of Virginia. In 2004, after completing a fellowship in hematology and oncology at the University of Michigan, Dr. Smerage joined the faculty of the Department of Internal Medicine and began his practice in the Breast Care Center. Dr. Smerage is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Smerage is board certified in Medical Oncology and Clinical Informatics.

Dr. Van Poznak received her medical degree from Cornell University Medical College and internal medicine residency training at The New York Hospital-Cornell Medical Center in New York City. Remaining in New York, she completed her fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center (MSKCC) and started her oncology practice at MSKCC on the Breast Cancer Medicine Service. In 2006, Dr. Van Poznak joined the faculty of the University of Michigan where she is an active clinician in the U-M Rogel Cancer Center Breast Care Center. Her clinical and translational research is in breast cancer and its relationship to bone - including the diagnosis, treatment and prevention of osteoporosis in breast cancer patients, breast cancer biomarkers predicting site specific relapse, and bone metastases. Dr. Van Poznak is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Van Poznak is board certified in Medical Oncology.

Dr. Mierzwa has 8 years of clinical experience in treatment of head and neck as well as gastrointestinal cancers. Her clinical research interests have included novel chemoradiation regimens for head and neck cancers as well as pancreatic cancer. Specifically, she is currently in collaboration with the Department of Otolaryngology as part of a clinical trial to identify radiographic and serum biomarkers for oropharynx cancer patients who may be eligible for de-escalation of chemoradiation. Dr. Mierzwa is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Dry Mouth, and Pancreaticoduodenectomy. Dr. Mierzwa is board certified in Radiation Oncology.

Dr. David Smith is a Professor of Internal Medicine and Urology at the University of Michigan and currently serves as the Associate Chief Clinical Officer for Cancer at Michigan Medicine and the Chief Medical Officer of the Rogel Cancer Center. Throughout his career he has focused on caring for patients with urologic cancers, cancer clinical trials, and the delivery of cancer care. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Orchiectomy, and Prostatectomy.

Oxana Crysler is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Crysler is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Crysler is board certified in Medical Oncology.

Dr. Palmbos received his bachelor’s degree from Calvin College in Grand Rapids, Michigan where he graduated with honors in 2000. He completed his combined M.D. and Ph.D. degrees as part of a NIH sponsored medical scientist training program at the University of Michigan Medical School in Ann Arbor, Michigan in 2008. His graduate work focused on the nonhomologous endjoining pathway of DNA double strand break repair. He then completed his Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Michigan in 2010 and 2014 respectively. His clinical interest is genitourinary malignancies and he primarily sees patients with bladder and prostate cancers. His laboratory research focus is on bladder cancer and he is currently developing new preclinical models of bladder cancer and focusing on the role of a novel oncogene, ATDC, in bladder tumor development. He recently received American Society of Clinical Oncology (ASCO) Young Investigator and Bladder Cancer Advocacy Network (BCAN) Young Investigator awards and has an NIH K08 award to develop his research program. Dr. Palmbos is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, and Urothelial Cancer. Dr. Palmbos is board certified in Internal Medicine and Medical Oncology.